ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,555,278 | -40.1% | 244,513 | -16.4% | 0.00% | -50.0% |
Q2 2023 | $7,600,838 | +27.1% | 292,565 | +40.5% | 0.00% | 0.0% |
Q1 2023 | $5,979,531 | +11.1% | 208,201 | +14.4% | 0.00% | 0.0% |
Q4 2022 | $5,384,000 | +18.2% | 181,943 | -4.9% | 0.00% | 0.0% |
Q3 2022 | $4,555,000 | -4.2% | 191,360 | -10.1% | 0.00% | 0.0% |
Q2 2022 | $4,753,000 | -13.1% | 212,953 | -2.3% | 0.00% | 0.0% |
Q1 2022 | $5,472,000 | -84.5% | 217,881 | -77.9% | 0.00% | -80.0% |
Q4 2021 | $35,385,000 | -16.4% | 987,648 | -0.7% | 0.01% | -28.6% |
Q3 2021 | $42,344,000 | -1.9% | 994,957 | -0.2% | 0.01% | +7.7% |
Q2 2021 | $43,167,000 | +6.1% | 997,172 | -0.0% | 0.01% | -7.1% |
Q1 2021 | $40,681,000 | -10.5% | 997,355 | -0.7% | 0.01% | -12.5% |
Q4 2020 | $45,445,000 | +27.5% | 1,004,108 | -0.3% | 0.02% | +14.3% |
Q3 2020 | $35,636,000 | +3.4% | 1,006,939 | +10.2% | 0.01% | -6.7% |
Q2 2020 | $34,461,000 | +85.0% | 913,365 | +41.8% | 0.02% | +50.0% |
Q1 2020 | $18,626,000 | -37.8% | 644,291 | +11.5% | 0.01% | -16.7% |
Q4 2019 | $29,964,000 | -15.4% | 577,888 | -10.5% | 0.01% | -25.0% |
Q3 2019 | $35,437,000 | -12.9% | 645,583 | -35.5% | 0.02% | -11.1% |
Q2 2019 | $40,664,000 | +108.7% | 1,001,079 | +55.4% | 0.02% | +100.0% |
Q1 2019 | $19,486,000 | +182.0% | 644,393 | +213.5% | 0.01% | +200.0% |
Q4 2018 | $6,909,000 | -18.4% | 205,544 | +2.3% | 0.00% | 0.0% |
Q3 2018 | $8,471,000 | +33.4% | 200,837 | +1.2% | 0.00% | 0.0% |
Q2 2018 | $6,350,000 | -63.0% | 198,436 | -42.4% | 0.00% | -62.5% |
Q1 2018 | $17,141,000 | +172.9% | 344,747 | +195.9% | 0.01% | +166.7% |
Q4 2017 | $6,280,000 | -9.2% | 116,494 | -2.3% | 0.00% | 0.0% |
Q3 2017 | $6,914,000 | +10.5% | 119,209 | -6.0% | 0.00% | 0.0% |
Q2 2017 | $6,257,000 | +21.6% | 126,803 | +7.0% | 0.00% | 0.0% |
Q1 2017 | $5,146,000 | +14.2% | 118,456 | +28.6% | 0.00% | +50.0% |
Q4 2016 | $4,508,000 | +28.9% | 92,094 | +26.0% | 0.00% | 0.0% |
Q3 2016 | $3,497,000 | -10.2% | 73,085 | +0.7% | 0.00% | 0.0% |
Q2 2016 | $3,893,000 | -2.8% | 72,560 | -19.0% | 0.00% | 0.0% |
Q1 2016 | $4,007,000 | +55.4% | 89,583 | +32.6% | 0.00% | 0.0% |
Q4 2015 | $2,578,000 | +16.3% | 67,575 | -2.9% | 0.00% | +100.0% |
Q3 2015 | $2,216,000 | -4.1% | 69,628 | -0.5% | 0.00% | 0.0% |
Q2 2015 | $2,311,000 | -20.3% | 69,995 | -0.6% | 0.00% | -50.0% |
Q1 2015 | $2,898,000 | +8.2% | 70,390 | +7.1% | 0.00% | 0.0% |
Q4 2014 | $2,678,000 | -10.2% | 65,724 | -19.2% | 0.00% | 0.0% |
Q3 2014 | $2,982,000 | -2.7% | 81,335 | +22.9% | 0.00% | 0.0% |
Q2 2014 | $3,065,000 | +58.1% | 66,165 | +40.2% | 0.00% | +100.0% |
Q1 2014 | $1,939,000 | +13.3% | 47,182 | +5.2% | 0.00% | 0.0% |
Q4 2013 | $1,712,000 | +9411.1% | 44,843 | +5887.0% | 0.00% | – |
Q3 2013 | $18,000 | -85.7% | 749 | -89.8% | 0.00% | – |
Q2 2013 | $126,000 | – | 7,339 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |